Loading clinical trials...
Loading clinical trials...
This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Cologne
NCT07249528 · Non-hodgkin Lymphoma, Multiple Myeloma
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT07275216 · Classic Hodgkin Lymphoma
NCT06386315 · Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma, and more
NCT03223610 · Lymphoma, Non-Hodgkin Lymphoma, and more
1st Dept. of Medicine, Cologne University Hospital
Cologne
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions